Palleiko Benjamin L

Chief Executive Officer | CFO, Cbo | President, CFO, Cbo &Sec'y +3 more

1 company

Average

Trades Analyzed

12M Win Rate

15.8%

Avg 3M Return

-4.4%

Avg 12M Return

-34.7%

Palleiko Benjamin L is a Chief Executive Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $12.5M based on current market prices.

Holdings by Company

KALVApr 17, 2026

Current Shares462.6K

Value$12.49M

Net Activity-330,210

Bought: 0Sold: 330.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 17, 2026	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	9,550	$20.22	$193,065.67	-2.0%	-	-
Dec 8, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	7,294	$16.51	$120,423.94	-1.7%	+2.6%	-
Nov 24, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	10,940	$13.45	$147,153.94	-2.6%	+16.5%	-
Nov 18, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	4,466	$14.48	$64,665.00	-1.1%	+5.0%	-
Nov 12, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	3,328	$11.55	$38,438.40	-0.8%	+12.5%	-
Sep 8, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	7,294	$15.84	$115,536.96	-1.8%	+5.6%	-
Aug 22, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	10,940	$13.22	$144,657.43	-2.8%	-2.9%	-
Aug 18, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	4,409	$13.19	$58,141.48	-1.2%	+11.4%	-
Jul 9, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sell	32,979	$15.69	$517,522.96	-8.2%	-31.7%	-
Jun 9, 2025	KALV Kalvista Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	7,169	$14.50	$103,950.50	-2.2%	+8.1%	+82.9%